Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Kereos develops products designed to provide more effective detection and treatment of cancer and cardiovascular disease. The first two products are expected to enter clinical trials for solid tumors late this year. The company’s proprietary technology pairs diagnosis and therapy by targeting imaging agents or therapeutics specifically to the disease site. The company’s targeted imaging agents allow for more accurate and sensitive imaging, and its targeted therapeutics deliver potent and precise ( www.kereos.com )
Kereos , Inc.
4041 Forest Park Ave.
St. Louis, Missouri 63108
USA
Tel: (314) 633-1879
Fax: (314) 633-1878